CapyFin

Calendar Reports

Search for a symbol...

Loading...

CapyFin Real-time Earnings Reports.

Products

Earnings
API

Get in Touch

Contact Us
X (Twitter)
LinkedIn

Resources

Privacy Policy
Terms of Service
Sign Up
Sign In

© 2026 CapyFin. All rights reserved.

Disclaimer: CapyFin provides financial data and AI analysis for informational purposes only and does not provide investment advice or recommendations. Real-time data and AI outputs may be inaccurate, incomplete, delayed, or contain errors or hallucinations. Investing involves risk, including loss of principal. The service is provided “as is” and we disclaim liability to the fullest extent permitted by law. See our Terms of Service and Privacy Policy.

CryoPort - CapyFin

CryoPort

CYRX · NASDAQ🇺🇸

Earnings Dividends Seasonality Metrics

Reported earnings 3 months ago

Previous year: $57.6M

Previous year: -$0.29

Commercial Cell & Gene Therapy Revenue

Global Clinical Trials Supported

Previous year: 684

Commercial Therapies Supported

Previous year: $25.2M

Cash and Equivalents

Previous year: $427M

Previous year: $852M

Loading...

Key Statistics

Market Cap

$476M

P/E Ratio

6.41

Sector

N/A

Industry

N/A

52-Week High

$11.3

52-Week Low

$4.68

Commercial Cell & Gene Therapy Revenue

$8.7M

Global Clinical Trials Supported

728

Commercial Therapies Supported

18

Phase 1 Clinical Trials

304

Phase 2 Clinical Trials

342

CryoPort

Unlock previous datapoints

CryoPort

Unlock previous datapoints

CryoPort Revenue by Segment

Revenue by Segment

Life Sciences Services Revenue

CapyFin.com

BioLogistics Solutions Revenue

CapyFin.com

BioStorage/BioServices Revenue

CapyFin.com

Life Sciences Products Revenue

CapyFin.com

Revenue & Expenses

Visualization of income flow from segment revenue to net income

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...